Press Releases

Improved technology and features will make it easier for patients living with Parkinson’s disease and healthy volunteers who want to advance medical research to find and connect to appropriate clinical trials

WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is introducing a redesigned version of its Fox Trial Finder clinical study matching tool powered by WCG CenterWatch iConnect. Use of the iConnect platform will make it easier for people with Parkinson’s disease (PD) and healthy volunteers to both find and participate in clinical trials.

“We are proud to be accelerating research and moving our mission forward to get safer, more effective treatments into the hands of patients living with Parkinson’s disease as efficiently as possible while maintaining the highest quality and ethical research standards. MJFF’s decision to redesign its new Fox Trial Finder on our iConnect platform will make clinical research much more accessible and easier to navigate for patients and their families,” said Donald A. Deieso, PhD, Executive Chairman and CEO of WCG.

“At the Foundation our single, urgent goal is to eliminate Parkinson’s disease. It will take the efforts of all of us to better connect the millions impacted by the disease worldwide to opportunities that could advance breakthroughs in treatments and ultimately a cure,” said MJFF Deputy CEO Sohini Chowdhury. “With 85 percent of trials facing delays and 30 percent never getting off the ground due to a lack of volunteers, the new Fox Trial Finder will reduce the burden of clinical trial recruitment by connecting patients and families to trials that urgently need them.”

WCG CenterWatch iConnect has the largest patient-friendly listing of actively enrolling clinical trials in the world. It is visited by more than 250,000 unique users per month, who are searching for information about clinical trials for which they, a friend or family member may qualify. CenterWatch also ranks in the top three of most clinical trial-related search results for any indication.

“MJFF’s Fox Trial Finder has traditionally been one of the ‘gold standards’ in matching patients to clinical trials. We are honored to provide MJFF with a more user-friendly version for their Parkinson’s community of patients, families and supporters around the globe,” added Lisa LaLuna, Senior Vice President Patient Advocacy at WCG.

WCG CenterWatch iConnect provides advanced trial listing technology for the largest patient advocacy groups in the world. It also allows sponsors to set up and manage all aspects of their patient recruitment programs from a single platform across the enterprise. This increased visibility enables them to determine the ROI and effectiveness of each tactic they employ across every study, improving predictability and reducing outreach expense.

People with Parkinson’s disease and healthy volunteers who would like to benefit from this new Fox Trial Finder are encouraged to browse the new clinical study matching tool at www.michaeljfox.org/trial-finder.

About WCG
WCG is the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. Comprised of two divisions – the industry’s first central IRB, and first clinical services organization (CSO) – WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protection. For more information, please visit www.wcgclinical.com  or follow us on Twitter @WCGClinical or LinkedIn.